E. BALOĞLU Et Al. , "In vivo Hypoxia and terbutaline treatment impairs beta 2 adrenergic signalling in ATII cells but blunts hypoxic inhibition of alveolar reabsorption," American Thoracic Society Meeting, New Orleans, Louisiana, ABD , 2010
BALOĞLU, E. Et Al. 2010. In vivo Hypoxia and terbutaline treatment impairs beta 2 adrenergic signalling in ATII cells but blunts hypoxic inhibition of alveolar reabsorption. American Thoracic Society Meeting, New Orleans, Louisiana, ABD .
BALOĞLU, E., Reingruber, T., Bartsch, P., & Mairbaurl, H., (2010). In vivo Hypoxia and terbutaline treatment impairs beta 2 adrenergic signalling in ATII cells but blunts hypoxic inhibition of alveolar reabsorption . American Thoracic Society Meeting, New Orleans, Louisiana, ABD
BALOĞLU, Emel Et Al. "In vivo Hypoxia and terbutaline treatment impairs beta 2 adrenergic signalling in ATII cells but blunts hypoxic inhibition of alveolar reabsorption," American Thoracic Society Meeting, New Orleans, Louisiana, ABD, 2010
BALOĞLU, Emel Et Al. "In vivo Hypoxia and terbutaline treatment impairs beta 2 adrenergic signalling in ATII cells but blunts hypoxic inhibition of alveolar reabsorption." American Thoracic Society Meeting, New Orleans, Louisiana, ABD , 2010
BALOĞLU, E. Et Al. (2010) . "In vivo Hypoxia and terbutaline treatment impairs beta 2 adrenergic signalling in ATII cells but blunts hypoxic inhibition of alveolar reabsorption." American Thoracic Society Meeting, New Orleans, Louisiana, ABD .
@conferencepaper{conferencepaper, author={Emel BALOĞLU Et Al. }, title={In vivo Hypoxia and terbutaline treatment impairs beta 2 adrenergic signalling in ATII cells but blunts hypoxic inhibition of alveolar reabsorption}, congress name={American Thoracic Society Meeting, New Orleans, Louisiana, ABD}, city={}, country={}, year={2010}}